High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in Kawasaki disease

Ho Chang Kuo, Mao Hung Lo, Kai Sheng Hsieh, Mindy Ming Huey Guo, Ying Hsien Huang

研究成果: 期刊稿件文章同行評審

62 引文 斯高帕斯(Scopus)

摘要

Background Kawasaki disease (KD) is also known as multiple mucocutaneous lymph node syndrome of systemic vasculitis and is a leading cause of coronary artery lesions (CAL) in childhood. Intravenous immunoglobulin (IVIG) has been proven to effectively reduce the incidence of CAL, but the role and effect dose of aspirin in KD is still unclear. Moreover, overt bleeding and anemia are associated with the use of aspirin, and anemia is common in patients with KD. Thus, the aim of this study was conducted to compare the treatment efficacy, degree of anemia and inflammation, and changes in serum hepcidin in children who received a combination of high-dose aspirin and IVIG in the acute stage of KD, and those who received IVIG alone.

原文英語
文章編號e0144603
期刊PLoS ONE
10
發行號12
DOIs
出版狀態已出版 - 01 12 2015

文獻附註

Publisher Copyright:
© 2015 Kuo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

指紋

深入研究「High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in Kawasaki disease」主題。共同形成了獨特的指紋。

引用此